Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees Hovingh

Showing results (1-10 of 322) with videos related to

Pageof 33
Sort By:
Thorax|January 26, 2019
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?Jurjan Aman, G Kees Hovingh
Nature Reviews. Endocrinology|November 10, 2017
Diabetes: Anti-PCSK9 antibodies - beneficial or inducers of diabetes?Rutger Verbeek, G Kees Hovingh
European Heart Journal|April 20, 2016
Familial hypercholesterolaemia: a common diseaseKausik K Ray, G Kees Hovingh
Lancet (London, England)|August 19, 2014
HDL and cardiovascular diseaseDaniel J Rader, G Kees Hovingh
Nature Reviews. Endocrinology|October 28, 2015
Dyslipidaemia: Lysosomal acid lipase deficiency-a cautious leap forwardCarla E M Hollak, G Kees Hovingh
Current Opinion in Lipidology|October 16, 2020
Proprotein convertase subtilisin/kexin type 9 inhibition as the next statin?Günaj Rakipovski, G Kees Hovingh, Michael Nyberg
Current Opinion in Lipidology|January 23, 2018
Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?Andrea Volta, G Kees Hovingh, Aldo Grefhorst
Circulation|September 8, 2016
Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too LittleG Kees Hovingh, John J P Kastelein
Science Bulletin|January 19, 2023
Studies into the association between LDL-C lowering and cognitive function: time to forget about it?Shirin Ibrahim, Laurens F Reeskamp, G Kees Hovingh
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs Boekholdt
Pageof 33

Showing results (1-10 of 322) with videos related to

Sort By:
Pageof 33
Thorax|January 26, 2019
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?Jurjan Aman, G Kees Hovingh
Nature Reviews. Endocrinology|November 10, 2017
Diabetes: Anti-PCSK9 antibodies - beneficial or inducers of diabetes?Rutger Verbeek, G Kees Hovingh
European Heart Journal|April 20, 2016
Familial hypercholesterolaemia: a common diseaseKausik K Ray, G Kees Hovingh
Lancet (London, England)|August 19, 2014
HDL and cardiovascular diseaseDaniel J Rader, G Kees Hovingh
Nature Reviews. Endocrinology|October 28, 2015
Dyslipidaemia: Lysosomal acid lipase deficiency-a cautious leap forwardCarla E M Hollak, G Kees Hovingh
Current Opinion in Lipidology|October 16, 2020
Proprotein convertase subtilisin/kexin type 9 inhibition as the next statin?Günaj Rakipovski, G Kees Hovingh, Michael Nyberg
Current Opinion in Lipidology|January 23, 2018
Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?Andrea Volta, G Kees Hovingh, Aldo Grefhorst
Circulation|September 8, 2016
Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too LittleG Kees Hovingh, John J P Kastelein
Science Bulletin|January 19, 2023
Studies into the association between LDL-C lowering and cognitive function: time to forget about it?Shirin Ibrahim, Laurens F Reeskamp, G Kees Hovingh
Current Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs Boekholdt
Pageof 33